Bromodeoxyuridine promotes full-chemical induction of mouse pluripotent stem cells
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Direct reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) with transcription factors (e.g., Oct4 (O), Sox2 (S), Klf4 (K), and c-Myc (M)) greatly expands our understanding of cell fate control. iPSCs resemble embryonic stem cells (ESCs) but without immune rejection and ethic issues, and are therefore considered as a promising source for cell replacement therapy. Patient-derived iPSCs can also be differentiated into disease-associated cell types and be used for drug screening 1 . However, iPSC applications are hindered by safety concerns about the possible genetic alterations caused by the use of exogenous pluripotency-associated factors. Many efforts have been taken to make iPSCs more amendable in clinical applications by using non-integrating gene delivery approaches 2 , or cell membrane-permeable proteins 3 , 4 to induce the reprogramming. Small-molecule compounds have also been found to be extremely useful in facilitating iPSC generation and can replace several reprogramming factors 5 . Several combinations of small-molecule compounds have been reported to allow iPSC generation with only Oct4 6 , 7 . However, complete chemical-mediated reprogramming of somatic cells into the pluripotent state has been proved to be extremely difficult. To date, only one study reported a seven- or four-chemical cocktail that can induce reprogramming 8 . Here we report that the commonly used biological reagent, bromodeoxyuridine (BrdU), is able to enhance Yamanaka factor-mediated reprogramming. More interestingly, BrdU can replace Oct4, the most critical factor in iPSC generation. Further studies demonstrate that BrdU promotes full-chemical induction of mouse iPSCs using several chemical cocktails, with the minimal combination being BrdU, CHIR99021, Repsox, and Forskolin. These iPSCs resemble ESCs in terms of their gene expression, epigenetic status, in vivo differentiation potentials and the ability to generate chimera. We have previously established a 96-well plate-based screening system ( Supplementary information, Figure S1A ) for chemicals that could affect OSKM-induced reprogramming of OG2 mouse embryonic fibroblasts (MEFs) stably carrying an Oct4 promoter-driven GFP reporter. Using this system we identified both LiCl and high osmotic pressure could enhance OSKM-mediated reprogramming of MEFs 9 , 10 . Unexpectedly, we also discovered that BrdU, a synthetic nucleoside that is an analog of thymidine and is commonly used in tracing DNA replication, was able to facilitate OSKM-induced reprogramming. About 40 GFP + colonies could be observed in BrdU-treated wells (starting from 4 000 MEFs/well), while only 1-2 colonies could be observed in the control well ( Figure 1A and 1B ). We treated the OSKM-infected MEFs with BrdU for various durations starting from day 3, 6 or 9 post infection ( Supplementary information, Figure S1B and S1C ). BrdU displayed remarkable effect at the early stage of reprogramming ( Supplementary information, Figure S1B ) and showed maximum effect if its treatment was maintained from day 3 to day 7 ( Supplementary information, Figure S1C ). BrdU could not maintain self-renewal of mESCs in LIF-free condition, and in the presence of LIF, BrdU even induced differentiation of mESCs ( Supplementary information, Figure S1D ). This explained why prolonged treatment of BrdU actually reduced the number of iPSC clones ( Supplementary information, Figure S1C ). Interestingly, the most effective concentration of BrdU in promoting reprogramming seems to vary according to the starting density of MEFs. The lower the starting MEF density, the lower the most effective concentration of BrdU ( Supplementary information, Figure S1E ). BrdU not only increased the number of GFP + cells, but also speeded up the reprogramming process. GFP + cells could be observed in BrdU-treated group as early as day 7 by FACS analysis ( Supplementary information, Figure S1F ), and more than 30% cells were GFP + on day 14 in BrdU group. Figure 1 The alternative text for this image may have been generated using AI. Full size image BrdU promotes full-chemical induced reprogramming of MEFs. (A) Dose-response effect of BrdU on OKSM-induced reprogramming of MEFs. Starting cell density was 4 000 MEFs/well (96-well plate). GFP + colonies were counted on day 14. (B) Representative images of GFP + colonies in a well of a 96-well plate on day 14 after induction. (C) iPSC generation with OSK and various concentrations of BrdU. GFP + colonies were counted on day 14. (D) iPSC generation with OK plus 3 μM CHIR99021, 1 μM RepSox and various concentrations of BrdU. GFP + colonies were counted on day 18. (E) iPSC generation with SKM and various concentrations of BrdU. GFP + colonies were counted on day 20. Data in A - E are presented as mean ± SEM of a representative experiment ( n = 3). * P < 0.05, ** P < 0.01, *** P < 0.001 (versus control). (F) MEFs were treated with a combination of seven small molecules including 0.5 mM VPA (V),
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins
Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., Ko, S., Yang, E., Cha, K. Y., Lanza, R., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.05.005 · Cited by 1,814
Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.
Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., Zhao, T., Ye, J., Yang, W., Liu, K., et al. (2013) · Science · doi:10.1126/science.1239278 · Cited by 1,402
Taupin, P. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.08.002 · Cited by 645
Cited by
Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails.
Fu, Y., Huang, C., Xu, X., Gu, H., Ye, Y., Jiang, C., Qiu, Z., & Xie, X. (2015) · Cell Research · doi:10.1038/cr.2015.99 · Cited by 248
Self-citationChromatin Accessibility Dynamics during Chemical Induction of Pluripotency
Cao, S., Yu, S., Li, D., Ye, J., Yang, X., Li, C., Wang, X., Mai, Y., Qin, Y., Wu, J., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.03.005 · Cited by 110
Chemical reprogramming for cell fate manipulation: Methods, applications, and perspectives
Wang, J., Sun, S., & Deng, H. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.08.001 · Cited by 91
Wang, B., Wu, L., Li, D., Liu, Y., Guo, J., Li, C., Yao, Y., Wang, Y., Zhao, G., Wang, X., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.068 · Cited by 64
Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies
Nath, S. C., Menendez, L., & Friedrich Ben-Nun, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316929 · Cited by 35
“Chemical programming is an attractive “zero-footprint” reprogramming method for clinical-grade iPSC generation [42–44]; however, most of the chemical reprogramming methods developed so far have used mouse cells because of their stable epigenome and high plasticity compared to human cells [45–48].”
Background
Metadata
- Authors
- Long, Y., Wang, M., Gu, H., & Xie, X.
- Venue
- Cell Research
- Published
- 2015-08-07
- Volume
- 25
- Issue
- 10
- Pages
- 1171-1174
- ISSN
- 1001-0602 (ISSN-L)
- 1748-7838
- OpenAlex
- W1954039280
- Cited by
- 69
- References
- 3
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bromodeoxyuridine promotes full-chemical induction of mouse pluripotent stem cells. https://app.cochat.ai/papers/10.1038/cr.2015.96
- The paper
- Long, Y., Wang, M., Gu, H., & Xie, X. (2015). Bromodeoxyuridine promotes full-chemical induction of mouse pluripotent stem cells. Cell Research. https://doi.org/10.1038/cr.2015.96
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.